Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Recent Pat Biotechnol ; 17(3): 271-288, 2023.
Article in English | MEDLINE | ID: mdl-36503455

ABSTRACT

BACKGROUND: As global awareness regarding climate change and environmental pollution outcomes arise, eco-friendly and negative emission technologies emerge. METHODS: In this scenario, polyhydroxyalkanoate (PHA)-accumulating microorganisms play an important role in the transition from the petrochemical-based non-biodegradable polymer to renewable, eco-friendly, and biocompatible materials. More specifically, CO2 can be converted to biopolymers through photosynthesis by cyanobacteria and algae, posing as a promising technology for renewable material, CO2, and petroleum-dependence mitigations. However, although many microorganisms can accumulate PHA intracellularly, limitations persist, such as the elevated cost and limited market availability. RESULTS: Herein is presented a patent-based mapping on technological trends of PHAs production, including its production by microalgae and cyanobacteria using the Questel Orbit Intelligence software (version 1.9.8) in complement with the Espacenet Patent Search database. CONCLUSION: The inquiry on PHAs retrieved 34,243 patents filed since 1912, whereas 156 are related to their specific production by photosynthetic microorganisms, evidencing a prospective market for intellectual property.


Subject(s)
Cyanobacteria , Polyhydroxyalkanoates , Carbon Dioxide , Prospective Studies , Patents as Topic
2.
Appl Biochem Biotechnol ; 192(3): 846-860, 2020 Nov.
Article in English | MEDLINE | ID: mdl-32607898

ABSTRACT

An alternative for non-biodegradable oil-based plastics has been the focus of many researchers throughout the years. Polyhydroxyalkanoates (PHAs) are potential substitutes due to their biodegradable characteristic and diversity of monomers that allow different biopolymer compositions and physical-chemical properties suitable for a variety of applications. The most well-known biopolymer from this class, poly(3-hydroxybutyrate) (P3HB), is already produced industrially, but its final price cannot compete with the oil-based plastics. As a low-volume high-value bioproduct, P3HB must be produced through a cheap and abundant feedstock, with high productivity and a feasible purity process in order to become an economically attractive bioproduct. In this scenario, we report a methylotrophic strain isolated from an estuarine contaminated site identified as Methylorubrum sp. highly tolerant to methanol and with great accumulation capacity of 60% (CDW) in 48 h through a simple strategy of batch fermentation with discontinuous methanol addition that could help lower P3HB's processing costs and final price.


Subject(s)
Methanol/pharmacology , Methylobacteriaceae/drug effects , Methylobacteriaceae/metabolism , Polyhydroxyalkanoates/metabolism , Biotechnology , Dose-Response Relationship, Drug , Fermentation
SELECTION OF CITATIONS
SEARCH DETAIL